Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment.
Author(s) -
Wayne M. Clark,
Fabien Calcagno,
Walter L. Gabler,
John R. Lindsay Smith,
Bruce M. Coull
Publication year - 1994
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.25.7.1411
Subject(s) - medicine , doxycycline , neuroprotection , paraplegia , central nervous system , anesthesia , ischemia , spinal cord injury , in vivo , pharmacology , reperfusion injury , spinal cord , antibiotics , biochemistry , chemistry , microbiology and biotechnology , psychiatry , biology
Activated leukocytes appear to potentiate central nervous system reperfusion injury, and agents that block leukocyte adhesion have shown neuroprotective efficacy in experimental models. Doxycycline, a tetracycline antibiotic, inhibits leukocyte function in vitro, presumably through divalent cation binding. We used a model of focal central nervous system reperfusion injury to determine the efficacy of doxycycline treatment in preserving neurological function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom